When Research Misconduct Violates the False Claims Act: Lessons from Duke's $112.5M Settlement

Published date03 April 2019
Law FirmTroutman Pepper
AuthorCallan Stein,Michael DePrince
Subject MatterDOJ,EPA,Whistleblowers,Qui Tam,Grants,Universities,NIH,Federal Funding,Medical Research,Falsified Documents,Settlement Agreements,False Claims Act (FCA),Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT